Palo Alto Investors as of Dec. 31, 2016
Portfolio Holdings for Palo Alto Investors
Palo Alto Investors holds 38 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| United Therapeutics Corporation (UTHR) | 15.3 | $268M | 1.9M | 143.43 | |
| Abiomed | 12.2 | $215M | 1.9M | 112.68 | |
| Clovis Oncology | 9.6 | $169M | 3.8M | 44.42 | |
| BioMarin Pharmaceutical (BMRN) | 9.3 | $162M | 2.0M | 82.84 | |
| AMAG Pharmaceuticals | 6.6 | $116M | 3.3M | 34.80 | |
| Alexion Pharmaceuticals | 5.0 | $87M | 714k | 122.35 | |
| Zeltiq Aesthetics | 4.3 | $75M | 1.7M | 43.52 | |
| Insmed (INSM) | 4.1 | $72M | 5.4M | 13.23 | |
| Vanda Pharmaceuticals (VNDA) | 3.8 | $67M | 4.2M | 15.95 | |
| Wright Medical Group Nv | 3.4 | $60M | 2.6M | 22.98 | |
| Sage Therapeutics (SAGE) | 2.9 | $52M | 1.0M | 51.06 | |
| Prothena (PRTA) | 2.8 | $49M | 994k | 49.19 | |
| ACADIA Pharmaceuticals (ACAD) | 2.5 | $44M | 1.5M | 28.84 | |
| STAAR Surgical Company (STAA) | 2.1 | $37M | 3.4M | 10.85 | |
| Epizyme | 2.1 | $37M | 3.0M | 12.10 | |
| Celgene Corporation | 1.9 | $34M | 295k | 115.75 | |
| Ariad Pharmaceuticals | 1.9 | $33M | 2.7M | 12.44 | |
| Amicus Therapeutics (FOLD) | 1.8 | $32M | 6.4M | 4.97 | |
| Karyopharm Therapeutics (KPTI) | 1.7 | $30M | 3.2M | 9.40 | |
| Momenta Pharmaceuticals | 1.5 | $26M | 1.7M | 15.05 | |
| Gilead Sciences (GILD) | 1.3 | $23M | 318k | 71.61 | |
| Shire | 1.2 | $21M | 124k | 170.38 | |
| Rigel Pharmaceuticals | 0.6 | $9.9M | 4.2M | 2.38 | |
| Aimmune Therapeutics | 0.4 | $7.8M | 380k | 20.45 | |
| EXACT Sciences Corporation (EXAS) | 0.3 | $5.3M | 397k | 13.36 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $4.2M | 1.2M | 3.62 | |
| Align Technology (ALGN) | 0.2 | $3.7M | 39k | 96.13 | |
| Alimera Sciences | 0.2 | $3.3M | 3.0M | 1.08 | |
| Acelrx Pharmaceuticals | 0.1 | $2.7M | 1.0M | 2.60 | |
| Cytokinetics (CYTK) | 0.1 | $1.5M | 124k | 12.15 | |
| Intrexon | 0.1 | $1.0M | 42k | 24.30 | |
| Idera Pharmaceuticals | 0.1 | $925k | 616k | 1.50 | |
| Cempra | 0.1 | $953k | 340k | 2.80 | |
| Sophiris Bio | 0.0 | $692k | 247k | 2.80 | |
| Alcobra | 0.0 | $573k | 273k | 2.10 | |
| Dicerna Pharmaceuticals | 0.0 | $456k | 158k | 2.88 | |
| Histogenics Corp Cmn | 0.0 | $506k | 303k | 1.67 | |
| Zogenix | 0.0 | $358k | 30k | 12.14 |
